BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22545089)

  • 1. Novel regulatory mechanisms for generation of the soluble leptin receptor: implications for leptin action.
    Schaab M; Kausch H; Klammt J; Nowicki M; Anderegg U; Gebhardt R; Rose-John S; Scheller J; Thiery J; Kratzsch J
    PLoS One; 2012; 7(4):e34787. PubMed ID: 22545089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The soluble leptin receptor.
    Schaab M; Kratzsch J
    Best Pract Res Clin Endocrinol Metab; 2015 Oct; 29(5):661-70. PubMed ID: 26522452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Leptin Receptor Predicts Insulin Sensitivity and Correlates With Upregulation of Metabolic Pathways in Men.
    Sommer C; Lee S; Gulseth HL; Jensen J; Drevon CA; Birkeland KI
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1024-1032. PubMed ID: 29300960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB
    Drori A; Gammal A; Azar S; Hinden L; Hadar R; Wesley D; Nemirovski A; Szanda G; Salton M; Tirosh B; Tam J
    Elife; 2020 Nov; 9():. PubMed ID: 33210603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary protein restriction increases hepatic leptin receptor mRNA and plasma soluble leptin receptor in male rodents.
    Yamada R; Odamaki S; Araki M; Watanabe T; Matsuo K; Uchida K; Kato T; Ozaki-Masuzawa Y; Takenaka A
    PLoS One; 2019; 14(7):e0219603. PubMed ID: 31306448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
    Guo S; Peng M; Zhao Q; Zhang W
    Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shedding of klotho by ADAMs in the kidney.
    van Loon EP; Pulskens WP; van der Hagen EA; Lavrijsen M; Vervloet MG; van Goor H; Bindels RJ; Hoenderop JG
    Am J Physiol Renal Physiol; 2015 Aug; 309(4):F359-68. PubMed ID: 26155844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases.
    Zhang L; Bukulin M; Kojro E; Roth A; Metz VV; Fahrenholz F; Nawroth PP; Bierhaus A; Postina R
    J Biol Chem; 2008 Dec; 283(51):35507-16. PubMed ID: 18952609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin increases hepatic leptin receptor and decreases steatosis in mice.
    Tang X; Li J; Xiang W; Cui Y; Xie B; Wang X; Xu Z; Gan L
    J Endocrinol; 2016 Aug; 230(2):227-37. PubMed ID: 27288055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).
    Raucci A; Cugusi S; Antonelli A; Barabino SM; Monti L; Bierhaus A; Reiss K; Saftig P; Bianchi ME
    FASEB J; 2008 Oct; 22(10):3716-27. PubMed ID: 18603587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells.
    Ebsen H; Schröder A; Kabelitz D; Janssen O
    PLoS One; 2013; 8(10):e76853. PubMed ID: 24130797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of neuregulin-1 by BACE1 or ADAM10 protein produces differential effects on myelination.
    Luo X; Prior M; He W; Hu X; Tang X; Shen W; Yadav S; Kiryu-Seo S; Miller R; Trapp BD; Yan R
    J Biol Chem; 2011 Jul; 286(27):23967-74. PubMed ID: 21576249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17.
    Shukla M; Htoo HH; Wintachai P; Hernandez JF; Dubois C; Postina R; Xu H; Checler F; Smith DR; Govitrapong P; Vincent B
    J Pineal Res; 2015 Mar; 58(2):151-65. PubMed ID: 25491598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles.
    Schumacher N; Meyer D; Mauermann A; von der Heyde J; Wolf J; Schwarz J; Knittler K; Murphy G; Michalek M; Garbers C; Bartsch JW; Guo S; Schacher B; Eickholz P; Chalaris A; Rose-John S; Rabe B
    J Biol Chem; 2015 Oct; 290(43):26059-71. PubMed ID: 26359498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble T cell immunoglobulin and mucin domain (TIM)-1 and -4 generated by A Disintegrin And Metalloprotease (ADAM)-10 and -17 bind to phosphatidylserine.
    Schweigert O; Dewitz C; Möller-Hackbarth K; Trad A; Garbers C; Rose-John S; Scheller J
    Biochim Biophys Acta; 2014 Feb; 1843(2):275-87. PubMed ID: 24286866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
    Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
    Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
    Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
    Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal cleavage and release of the ectodomain of Flt1 is mediated via ADAM10 and ADAM 17 and regulated by VEGFR2 and the Flt1 intracellular domain.
    Raikwar NS; Liu KZ; Thomas CP
    PLoS One; 2014; 9(11):e112794. PubMed ID: 25387128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.
    Schulz B; Pruessmeyer J; Maretzky T; Ludwig A; Blobel CP; Saftig P; Reiss K
    Circ Res; 2008 May; 102(10):1192-201. PubMed ID: 18420943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
    Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
    Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.